Timothy A Springer bought $2.3M of TECX
director, owner at Tectonic Therapeutic, Inc.. 141,923 shares at an average of $16.20, traded Apr 9, 2025, filed Apr 11, 2025.
Score components
- +15RoleDirector
- +25Trade size$2.3M at market
- 0Relative to holdingsHoldings up 3.3%
- +8Price context69% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (2 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +22.3%, 3m +40.1%, 6m -0.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-010588, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 9, 2025 | POpen-market purchase Common Stock | +2,861 | $14.62 | $42k | 4,316,419 | Apr 11, 2025 |
| Apr 9, 2025 | POpen-market purchase Common Stock | +857 | $15.23 | $13k | 4,317,276 | Apr 11, 2025 |
| Apr 10, 2025 | POpen-market purchase Common Stock | +8,092 | $16.73 | $135k | 4,325,368 | Apr 11, 2025 |
| Apr 11, 2025 | POpen-market purchase Common Stock | +9,478 | $16.31 | $155k | 4,334,846 | Apr 11, 2025 |
| Apr 9, 2025 | POpen-market purchase Common Stockindirect: By LLC | +16,215 | $14.62 | $237k | 1,398,938 | Apr 11, 2025 |
| Apr 9, 2025 | POpen-market purchase Common Stockindirect: By LLC | +4,856 | $15.23 | $74k | 1,403,794 | Apr 11, 2025 |
| Apr 10, 2025 | POpen-market purchase Common Stockindirect: By LLC | +45,858 | $16.73 | $767k | 1,449,652 | Apr 11, 2025 |
| Apr 11, 2025 | POpen-market purchase Common Stockindirect: By LLC | +53,706 | $16.31 | $876k | 1,503,358 | Apr 11, 2025 |
Related signals
Other insiders at Tectonic Therapeutic, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Tectonic Therapeutic, Inc. | Peter McNamara Chief Scientific Officer | $12k 536 shares | -1% | |
| 0Weak | Tectonic Therapeutic, Inc. | Peter McNamara Chief Scientific Officer | $1,570 43 shares | -0% | |
| 0Weak | Tectonic Therapeutic, Inc. | Peter McNamara Chief Scientific Officer | $1,505 43 shares | -0% | |
| 0Weak | Tectonic Therapeutic, Inc. | Peter McNamara Chief Scientific Officer | $6,020 172 shares | -0% | |
| 0Weak | Tectonic Therapeutic, Inc. | Marcella K. Ruddy Chief Medical Officer | $32k 1,065 shares | -2% | |
| 0Weak | Tectonic Therapeutic, Inc. | Marcella K. Ruddy Chief Medical Officer | $31k 1,000 shares | -1% | |
| 5Weak | Tectonic Therapeutic, Inc. | Peter McNamara Chief Scientific Officer | $189k 6,262 shares | -10% | |
| 22Weak | Tectonic Therapeutic, Inc. | Marcella K. Ruddy Chief Medical Officer | $300k 10,000 shares | -13% | |
| 12Weak | Tectonic Therapeutic, Inc. | Peter McNamara Chief Scientific Officer | $78k 3,299 shares | -8% | |
| 48Moderate | Tectonic Therapeutic, Inc. | Alise Reicin Chief Executive Officer | $53k 2,500 shares | +2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.